Announcements Trials

Browse Landscape

Phase

Phase 2 50 Phase 1 17 Phase 3 15 Phase 1/2 14 Phase 2/3 2 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Magnetic Resonance Spectroscopy 12 pembrolizumab 9 Biopsy 8 Nivolumab 7 Radiotherapy 6 Specimen Handling 5 Radiosurgery 4 Cyclophosphamide 4 fludarabine 3 X-Rays 3 Temozolomide 3 Rituximab 3 Paclitaxel 3 Leukapheresis 3 Dexamethasone 3 Aspirin 3 perflutren 2 alovudine 2 Vaccines 2 Tirzepatide 2 Surgical Procedures, Operative 2 Positron-Emission Tomography 2 Phantoms, Imaging 2 Niacinamide 2 Neoadjuvant Therapy 2 Losartan 2 Letrozole 2 Ketoconazole 2 Irinotecan 2 Ipilimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × olaparib × 90 days × Clear all

NCT04614909 2026-05-14

Study of Pamiparib in Newly Diagnosed and rGBM

St. Joseph's Hospital and Medical Center, Phoenix

Phase EARLY_PHASE1 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡